Vimarsana
Biggest News Aggregation in the World

Page 4 - Presenting Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presenting Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presenting Cells Today - Breaking & Trending Today

SQZ Biotechnologies (NYSE:SQZ) Expected to Post Quarterly Sales of $4.17 Million - Vimarsana News

SQZ Biotechnologies (NYSE:SQZ) Expected to Post Quarterly Sales of $4.17 Million

Wall Street brokerages expect SQZ Biotechnologies (NYSE:SQZ – Get Rating) to post $4.17 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for SQZ Biotechnologies’ earnings, with estimates ranging from $3.00 million to $4.92 million. SQZ Biotechnologies posted sales of $4.54 million in the same quarter last […]

SQZ Biotechnologies (NYSE:SQZ) Expected to Post Earnings of -$0.76 Per Share - Vimarsana News

SQZ Biotechnologies (NYSE:SQZ) Expected to Post Earnings of -$0.76 Per Share

Wall Street brokerages predict that SQZ Biotechnologies (NYSE:SQZ – Get Rating) will report earnings per share (EPS) of ($0.76) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for SQZ Biotechnologies’ earnings, with the lowest EPS estimate coming in at ($0.82) and the highest estimate coming in at ($0.71). SQZ […]

Head-To-Head Survey: Adaptive Biotechnologies (NASDAQ:ADPT) versus SQZ Biotechnologies (NYSE:SQZ) - Vimarsana News

Head-To-Head Survey: Adaptive Biotechnologies (NASDAQ:ADPT) versus SQZ Biotechnologies (NYSE:SQZ)

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) and SQZ Biotechnologies (NYSE:SQZ – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability and risk. Volatility and Risk Adaptive Biotechnologies has a beta of […]

Zacks: Brokerages Anticipate SQZ Biotechnologies (NYSE:SQZ) Will Post Quarterly Sales of $5.41 Million - Vimarsana News

Zacks: Brokerages Anticipate SQZ Biotechnologies (NYSE:SQZ) Will Post Quarterly Sales of $5.41 Million

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Zacks: Analysts Anticipate SQZ Biotechnologies (NYSE:SQZ) to Announce -$0.71 Earnings Per Share - Vimarsana News

Zacks: Analysts Anticipate SQZ Biotechnologies (NYSE:SQZ) to Announce -$0.71 Earnings Per Share

Wall Street analysts expect that SQZ Biotechnologies (NYSE:SQZ – Get Rating) will announce ($0.71) earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for SQZ Biotechnologies’ earnings, with the highest EPS estimate coming in at ($0.70) and the lowest estimate coming in at ($0.71). SQZ Biotechnologies […]